News tagged with institute

Beleodaq approved for aggressive non-hodgkin lymphoma

(HealthDay)—Beleodaq (belinostat) has been approved by the U.S. Food and Drug Administration to treat peripheral T-Cell lymphoma (PTCL), a rare and aggressive form of non-Hodgkin lymphoma (cancer of the lymph nodes).

Jul 03, 2014
popularity 5 / 5 (2) | comments 0

CT scans lower lung cancer deaths, according to study

In response to a recent national study showing that CT scans in a select high-risk population lower lung cancer deaths, NewYork-Presbyterian/Weill Cornell Medical Center has launched a lung cancer screening ...

Jul 03, 2014
popularity not rated yet | comments 0